Actively Recruiting
Hemithoracic Arc Radiotherapy Post Pleural Decortication
Led by Cairo University · Updated on 2025-04-08
45
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication
CONDITIONS
Official Title
Hemithoracic Arc Radiotherapy Post Pleural Decortication
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Evidence of metastatic disease
- Underwent Pleural decortication
- Able to provide informed consent
You will not qualify if you...
- Poor pulmonary function tests
- Recurrent or palliative cases
- Inability to attend full course of Radiotherapy or follow up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
national Cancer Institute Cairo university
Cairo, Fom Elkhalig, Egypt, 11796
Actively Recruiting
Research Team
G
Gamal
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here